Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. The Mount Sinai Physician’s Channel will show you some of the innovative procedures, new developments in patient care, and complex cases that are being performed in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field, and others.
Or call 212-241-4983
Recently Added
At Mount Sinai, we are relentless in our mission to overcome some of the most perplexing health and scientific problems of our time—always with an eye to the patients and communities we serve. In this issue, we offer a glimpse into how ...
Mount Sinai Experts Explain What the Omicron Variant Means for You
Currently, there is insufficient data on how easily the Omicron variant may be transmitted or whether it produces more serious illness.
Monkeypox
Curious About the Monkeypox Vaccine? Here’s What You Need to Know
Richard Silvera, MD, MPH of Mount Sinai details important information about monkeypox vaccination.
Cardiology & Cardiovascular Surgery | View More
Valentín Fuster, MD, PhD, Named President of Mount Sinai Heart
Mount Sinai Health System’s globally acclaimed cardiologist Valentín Fuster, MD, PhD, has been named President of Mount Sinai Heart, a newly created position, effective Sunday, January 1, 2023.
Deepak L. Bhatt, MD, MPH, Named Director of Mount Sinai Heart
Deepak L. Bhatt, MD, MPH, a top expert in cardiovascular medicine and interventional cardiology, has been named Director of Mount Sinai Heart.
Annapoorna S. Kini, MD, Reports on Latest YELLOW III Study Results
Twenty-six weeks of PCSK9 inhibitor therapy on top of maximally tolerated statins increases markers of plaque stability in patients with stable coronary artery disease, according to the YELLOW III trial, led by Annapoorna S. Kini, MD, ...
Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG regardless of their background lipid-modifying therapy status.
Dermatology | View More
The research training program in Systems Skin Biology will take a multidisciplinary approach in teaching scientists to holistically understand human physiology, health, and disease.
New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped.
Brian S. Kim, MD, MTR, presented virtually as a keynote speaker, at the Anesthesiology Branch of Chinese Geriatric Society 2022 Annual Meeting, Tianjin, China. This popular presentation’s total online viewing clicks were more than 400,000 during the meeting.
Brian S. Kim, MD, MTR, received the inaugural Stephen I Katz, MD, PhD, International Lectureship Award and presented "Neuroimmune Regulation of Itch" at the Society for Investigative Dermatology (SID) annual meeting in Portland, Oregon in May 2022.
Diabetes & Endocrinology | View More
Gaining Genomic Insights Into the Mechanisms and Classification of PCOS
Andrea Dunaif, MD, Chief of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, a world leader in the study of disorders of metabolism and reproduction, is heading ...
Endocrine, Diabetes and Bone Disease Specialty Report 2023
The Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai is dedicated to advancing the understanding and treatment of diabetes, obesity, conditions affecting ...
JDRF Recognizes Mount Sinai’s Contribution to Diabetes Research and Patient Care
Mount Sinai was honored by the Juvenile Diabetes Research Foundation at their annual Promise Ball for its type 1 diabetes research and patient care, with particular recognition of Carol J. Levy, MD, and Andrew F. Stewart, MD.
Study Is Investigating Role of Pituitary Hormone Deficiency in Post-COVID Fatigue
Mount Sinai’s Center for Post-COVID Care is part of a novel, multisite study that is investigating whether abnormal pituitary hormone levels are implicated in post-COVID fatigue, a prevalent and debilitating condition.
Gastroenterology & GI Surgery | View More
Targeting Disease Prediction and Prevention: The New Frontier in IBD
Mount Sinai researchers have found strong evidence that before the first symptoms of Crohn’s disease and ulcerative colitis occur, there’s a preclinical phase in which immune and inflammatory pathways are already altered.
Vedolizumab Versus Adalimumab for Moderate to Severe Ulcerative Colitis
In the first clinical trial to evaluate two biologic therapies for moderate to severe ulcerative colitis (UC) head to head, Mount Sinai researchers found vedolizumab to be superior to adalimumab in a variety of measures.
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
Ustekinumab is more effective than placebo as an induction and maintenance therapy for UC.
Geriatrics | View More
Geriatrics and Palliative Medicine Specialty Report 2023
The Mount Sinai Hospital is ranked No. 1 in Geriatrics in the nation by U.S. News & World Report for the third consecutive year.
Leslie Kerr, MD, in a Grand Rounds presentation on joint inflammation
Treatment for crystals in synovial fluid in patients with multiple medical issues
Albert L. Siu, MD, presents Grand Rounds on geriatrics and palliative care
Hospitalization at Home
Forty Years of Excellence: Research Focused on Patient Needs
Robert Butler, MD, having previously founded and chaired the National Institute on Aging, quickly established a highly successful culture of research, and that culture continues to flourish.
Interventional Radiology | View More
Mount Sinai Neurosurgery Chair, Joshua Bederson, MD Case Study: Brain Tumor Embolization
The Benefits of Preoperative Embolization for Treating Meningiomas and Other Skull Base Tumors
An advanced radiotherapy technique called radiation segmentectomy may be effective against very early to early-stage hepatocellular carcinoma (HCC), a type of liver cancer that cannot be treated surgically or thermally.
Prostatic Artery Embolization at Mount Sinai
Watch a PAE on a 74-year-old with a 20-year history of BPH
An Overview of Minimally Invasive Prostate Artery Embolization at Mount Sinai
Hear directly from Aaron Fischman, MD, about how effectively PAE works for patients with urinary symptoms caused by BPH
Neurology & Neurosurgery | View More
Mount Sinai Neurosurgery Chair, Joshua Bederson, MD Case Study: Brain Tumor Embolization
The Benefits of Preoperative Embolization for Treating Meningiomas and Other Skull Base Tumors
Simultaneous Minimally Invasive Surgery (MIS) for Spontaneous Intracerebral Hemorrhage (sICH) Evacuation and Pulmonary Embolectomy (PE)
Deep Brain Stimulation (DBS) for Obsessive-Compulsive Disorder (OCD)
View the Pre- and Post- Operative Presentation of Deep Brain Stimulation (DBS) Procedure to Treat Obsessive-Compulsive Disorder (OCD)
Mount Sinai Neurosurgeon presents Efficient, Radiation-Free Navigation: Ushering in a New Era of Spine Surgery
Nuclear Medicine | View More
This large study of patients undergoing PET MPI demonstrated that although reduced MBFR was more prevalent in women compared with men, there were no sex-specific differences in the prognostic value of reduced MBFR.
This study reviews the need for a separate risk threshold with PET and SPECT while selecting a high-risk population as the target for an intervention.
Use of anatomic testing such as coronary artery calcium scoring (CACS) of 0 to avoid myocardial perfusion imaging in symptomatic patients could lead to missing microvascular dysfunction in 4 out of 10 patients, a finding associated with a high mortality risk.
Myocardial perfusion imaging (MPI) identifies abnormalities that occur early in the ischemic cascade leading to angina.
Obstetrics & Gynecology | View More
Oncology | View More
Tremendous progress has been made in improved survival and quality of life for multiple myeloma patients. Continued advancements in effective treatment options has changed the outlook for patients and physicians.
The Mount Sinai Health System’s esophagectomy program has received a three-star (excellent performance) overall composite score from the Society of Thoracic Surgeons (STS).
Mount Sinai Launches Children’s Brain and Spinal Tumor Center
Mount Sinai's new Children’s Brain and Spinal Tumor Center will focus on innovative translational research, bridging basic science with the clinical care of children with brain and spinal tumors.
Two Renowned Cancer Experts to Head New Tisch Cancer Hospital at The Mount Sinai Hospital
Cardinale B. Smith, MD, PhD, has been appointed Chief Medical Officer for the Tisch Cancer Hospital and Vice President of Cancer Clinical Affairs, and Ash Tewari, MBBS, MCh, has been appointed Surgeon-in-Chief of the Tisch Cancer Hospital.
Ophthalmology | View More
New York Eye and Ear Infirmary of Mount Sinai (NYEE) 2022 Specialty Report
We are pleased to share with you the Department of Ophthalmology 2022 Specialty Report, which showcases the tremendous work happening at our institution, as we continue to envision our third century of community care, vision research, and education.
A Mount Sinai Resident Draws on a Diverse Team to Address a Traumatic Eye Injury
The case of a 56-year-old man with a 10mm shard of metal penetrating his left eye shows the importance of triage in ensuring the best outcomes.
Surgeons at NYEE and Mount Sinai Team Up for a Five-Year-Old Patient
Technology and surgical skills come together as surgeons team up to repair an arteriovenous malformation in the orbit compressing the optic nerve.
Two Powerful Imaging Tools Make Their Debut in the United States
Technology continues to hold center stage at New York Eye and Ear Infirmary of Mount Sinai (NYEE), underscored by the recent arrival of two cutting-edge imaging devices: a tear film analyzer and an optical coherence tomography (OCT) Doppler.
Orthopedics | View More
Orthopedic Surgery Specialty Report 2023
Since 1910, Mount Sinai’s Department of Orthopedic Surgery has been dedicated to understanding health conditions spanning the field of orthopedics.
Surgeon Paves the Way for Non-Fusion Correction of Scoliosis
Mount Sinai orthopedic surgeon Baron S. Lonner, MD, is leading the charge to add vertebral body tethering to the spine surgeon’s toolbox.
During the 2021-2022 academic year, the Department of Orthopedic Surgery at the Icahn School of Medicine at Mount Sinai added three talented physicians to its roster: Joseph Lee, MD, Nilsson Holguin, MD, and Fei Fang, PhD.
3D Printing Provides a Sturdy Pillar for Total Ankle Replacement Surgery
Conventional structural bone grafts for ankle and foot reconstruction are difficult to contour to a patient’s anatomy and often degrade over time.
Otolaryngology/ENT | View More
On Wednesday, January 13, 2021, a team of brilliant medical professionals conducted the first successful human trachea transplant. This special report details the research and process leading up to this historic surgery, as well as the ...
How Surgeons Performed the First Successful Human Trachea Transplant
More than 50 specialists were involved in the first successful human trachea transplant. The skilled team spent 18 hours harvesting trachea from a donor and implanting it into the patient
Otolaryngology - Head and Neck Surgery Specialty Report 2023
Eric M. Genden, MD, MHA, FACS, Professor and Chair, Otolaryngology-Head and Neck Surgery, reflects on a bold year for the Department that resulted in groundbreaking research and the adoption of cutting-edge technology.
Genetic Causes of Three Previously Unexplained Rare Diseases Identified
Mount Sinai researchers help identify previously unknown genetic causes of primary lymphedema, thoracic aortic aneurysm disease, and congenital deafness.
Mount Sinai Kravis Children's Hospital| View More
Register Today for the 14th Annual Symposium: The Right Heart - Conversations in Care
This year’s conference will focus on common and controversial questions that arise in the care of important lesions affecting the right heart.
Lisa Satlin, MD shares insights on Pediatrics
Lisa Satlin, MD, Shares Insights on Pediatrics at Mount Sinai Kravis Children’s Hospital
Jeffrey M. Saland, MD discusses determining "normal" blood pressure in children
Jeffrey M. Saland, MD, on Determing “normal” Blood Pressure in Children
Alfin Vicencio, MD discusses his success with precision medicine
Alfin Vicencio, MD, Targets Asthma in Children With Precision Medicine
Psychiatry| View More
Psychiatry Specialty Report 2023
The year 2022 was a productive and prolific one for our department. We launched the Center for Disease Neurogenomics—one of the few in the world with access to brain tissue and population-level datasets.
Mount Sinai Receives Grant to Support Behavioral Health
A grant from the New York State Office of Mental Health will help patients at Mount Sinai’s Cohen Center for Pediatric Comprehensive Care (CCPCC), which serves more than 10,000 families, gain access to HealthySteps, a national evidence-based ...
This study is the first to examine in utero exposure to stimulants and long term child outcomes. Researchers examined almost 900 children who were exposed to ADHD during the mothers’ pregnancy and 1270 children who were not.
Mount Sinai Researchers Have Identified Two Previously Unknown Genes Linked to Schizophrenia
Researchers have identified two previously unknown genes linked to schizophrenia and newly implicated a third gene as carrying risk for both schizophrenia and autism.
Pulmonology | View More
Pulmonary, Critical Care and Sleep Medicine Specialty Report 2023
We challenged expectations to achieve progress in 2022 in areas ranging from asthma to pleuroscopy, exercise physiology, and lung transplant.
Asthma and COPD Expert Is Mount Sinai's New Chair of Medicine
Mount Sinai has named Monica Kraft, MD, as its new Chair of Medicine. She will now lead a department she has long collaborated with on research.
A new Mount Sinai research program aims to map the developing pediatric airway from minimally invasive respiratory samples obtained during flexible bronchoscopy, with the goal of advancing cystic fibrosis therapeutics and enabling the ...
Mount Sinai's New Lung Transplantation Program Takes on Complex Cases
Mount Sinai’s Scott Scheinin, MD, and Harish Seethamraju, MD, are establishing the End-Stage Lung Disease and Transplant Program as a leader in treating complex cases.
Rehabilitation | View More
Quad Gods Defy the Odds, Take Gaming to New Heights
A patient struggling to adjust to his quadriplegia gains the idea to form a competitive e-sports team with other similar patients from Mount Sinai, and the team has gone on to win tournaments, even against other players without disabilities.
At Mount Sinai’s Lazarus Center, Kids Take Center Stage
The mission of the Charles Lazarus Children’s Abilities Center at the Icahn School of Medicine at Mount Sinai is ambitious: To provide children who have disabilities with every tool, resource, and opportunity possible to achieve their full potential.
Toy Car-Making Hackathon Helps Kids With Disabilities
Members of the Charles Lazarus Children’s Abilities Center got together to participate in a hackathon to reimagine ride-on toy cars for children with disabilities, turning physical therapy into a fun and memorable experience.
Minimally Invasive Technology Offers Paralyzed People Greater Function
For the first time in the United States, people with severe paralysis are receiving minimally invasive implants that allow them to communicate and perform computer-based tasks at home.
Urology | View More
Message from the Chair: Milestones are meant to be celebrated and surpassed. For the year 2022, our milestones are a reflection of our collective efforts to save lives—through innovative patient care and groundbreaking research and scholastic activities.
Case Study: Multidisciplinary Care for Renal Replacement Patient
A neonate with severe kidney injury and likely urinary blockage causing severe hydronephrosis received successful treatment at Mount Sinai for his rare birth defect.
Organoids Enable Pathophysiology, Treatment Studies of Rare Renal Cell Carcinomas
For years, rare renal cell carcinomas (RCCs), such as papillary RCC, have been understudied because their incidences are too low to support clinical trials.
Better Diagnosis Holds the Key to Improved Outcomes for BPH Patients
As the family of technologies for treating benign prostatic hyperplasia (BPH) continues to grow, the key to successful outcomes for male patients may well rest on a rather simple tenet: better diagnostic acumen.
Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. The Mount Sinai Physician’s Channel will show you some of the innovative procedures, new developments in patient care, and complex cases that are being performed in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field, and others.